PTEN RESEARCH FOUNDATION
Get an alert when PTEN RESEARCH FOUNDATION files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-11-26 (in 6mo)
Last made up 2025-11-12
Watchouts
None on the register
Cash
£4M
+11.4% vs 2024
Net assets
£21M
-10.8% vs 2024
Employees
6
0% vs 2024
Profit before tax
—
Period ending 2025-03-31
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | £681,591 | £715,577 | |
| Operating profit | -£3,682,082 | -£2,530,891 | |
| Profit before tax | — | — | |
| Net profit | -£2,657,798 | -£2,557,520 | |
| Cash | £3,828,592 | £4,265,650 | |
| Total assets less current liabilities | — | — | |
| Net assets | £23,741,548 | £21,184,028 | |
| Equity | £23,741,548 | £21,184,028 | |
| Average employees | 6 | 6 | |
| Wages | £521,857 | £522,028 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating margin | -540.2% | -353.7% | |
| Net margin | -389.9% | -357.4% | |
| Current ratio | 21.44x | 56.91x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Crowe U.K. LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“With due regard to the Foundation's finances and projected expenditure, the Trustees remain satisfied that it has sufficient resources to continue as a going concern for at least 12 months after the approval of the financial statements to which this report relates.”
Significant events
- “Four new grants were approved by the Trustees between 1 April 2024 and 31 March 2025 (of which one was lost to follow-up during the contracting period, and three were initiated in a later period).”
- “The Foundation launched a new targeted call for basic and translational research projects addressing key knowledge gaps in the pathobiology of PHTS.”
- “The Foundation continues to support clinical trial preparations in collaboration with a US academic consortium for repurposing of a rapalog in PHTS where the investigational new drug (IND) application from the U.S. Food and Drug Administration (FDA) has cleared.”
- “The Foundation continues clinical trial preparations and regulatory approval applications in collaboration with a major pharma company and US based academic consortium to support repurposing of a recently approved medication originally approved in oncology for individuals with PHTS.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BALDINI, Siriana | Director | 2021-05-11 | May 1973 | British,Italian |
| CLARK, Susannah | Director | 2016-12-16 | Feb 1979 | Australian |
| CROME, Renata | Director | 2021-05-11 | Jul 1955 | British |
| WILLIAMS, Robert John, Doctor | Director | 2022-01-21 | Nov 1961 | British |
| ZACCONI, Riccardo | Director | 2016-12-16 | May 1967 | Italian |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BEDFORD, Philip, Dr | Director | 2021-05-11 | 2022-01-19 |
| TESEI, Alessandro | Director | 2016-12-16 | 2019-05-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ms Siriana Baldini | Individual | Significant influence | 2021-05-05 | Active |
| Blue Compass Ptc Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-12-16 | Ceased 2016-12-16 |
| Alexandre Maurus Semboglou | Individual | Significant influence | 2016-12-16 | Active |
| David Gustave Goar | Individual | Significant influence | 2016-12-16 | Active |
| Alessandro Tesei | Individual | Significant influence | 2016-12-16 | Active |
Filing timeline
Last 20 of 45 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-04 | AA | accounts | Accounts with accounts type full | |
| 2025-11-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-24 | AA | accounts | Accounts with accounts type full | |
| 2024-12-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-08 | AA | accounts | Accounts with accounts type full | |
| 2023-12-01 | CH01 | officers | Change person director company with change date | |
| 2023-12-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-18 | CH01 | officers | Change person director company with change date | |
| 2023-07-26 | CH01 | officers | Change person director company with change date | |
| 2023-06-07 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-04-26 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-04-26 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-04-26 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-04-26 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-02-22 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-02-22 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-02-22 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-02-22 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-02-14 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-12-23 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
+5%
£681,591 £715,577
-
Cash
+11.4%
£3,828,592 £4,265,650
-
Net assets
-10.8%
£23,741,548 £21,184,028
-
Employees
0%
6 6
-
Operating profit
+31.3%
-£3,682,082 -£2,530,891
-
Wages
0%
£521,857 £522,028
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers